PUBLISHER: IMARC | PRODUCT CODE: 1468096
PUBLISHER: IMARC | PRODUCT CODE: 1468096
Anti-Venom Market Report by Species, Anti-venom Type, Mode of Action, End User, and Region 2024-2032
The global anti-venom market size reached US$ 1,169.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,003.5 Million by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The rising incidences of snake bites and scorpion stings, the implementation of favorable government initiatives, and ongoing innovations in the industry represent some of the key factors driving the market.
Anti-venom, also known as venom antiserum, refers to a type of medication used to treat the effects of venomous bites or stings from animals, including snakes, spiders, scorpions, and certain marine creatures such as jellyfish or cone snails. It is obtained by extracting venom from the offending animal and then injecting small amounts of the venom into animals, such as horses, sheep, or goats, whose immune systems produce antibodies that are harvested and purified to create anti-venom. Anti-venom neutralizes the toxins and counteracts the effects of the venom, preventing them from causing life-threatening complications such as respiratory failure or organ damage. It is extensively adopted across the globe in treating venomous bites and stings, depending on their history, examination, and geographic, clinical, and pathologic factors.
Anti-Venom Market Trends:
The rise in cases of venomous bites and stings across the world, particularly in rural and tropical regions and among agricultural workers and hunters, represents one of the prime factors driving the market growth. Besides this, the escalating consumer awareness of the importance of snake bite prevention and easy product availability at an affordable price is creating a favorable outlook for the market. Moreover, the implementation of numerous government initiatives to combat snake bites, such as education and training programs, and intensive investments in research and development (R&D) activities of new anti-venom products are contributing to the market growth. In addition to this, with the rising demand for animal-based protein, there is an increase in the number of livestock and other animals at risk of snake bites, which, in turn, is presenting remunerative growth opportunities for the market. Concurrent with this, the rising popularity of traveling and exploring exotic destinations, such as islands, deserts, jungles, and safaris, that puts tourists at risk of snake bites and other venomous animal encounters is acting as another significant growth-inducing factor. Furthermore, numerous technological advancements in the biotechnology and healthcare industries and ongoing innovative improvements in manufacturing technology, allowing for the production of more effective and efficient anti-venom products, are positively impacting the market growth. Apart from this, the launch of various rapid snake venom detection kits, which utilize a rapid enzyme immunoassay to detect and identify snake venom through samples taken from bite sites, urine, plasma, blood, or other tissues and body fluids, is propelling the market forward.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-venom market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on species, anti-venom type, mode of action and end user.
Species Insights:
Snake
Scorpion
Spider
Others
The report has provided a detailed breakup and analysis of the anti-venom market based on the species. This includes snake, scorpion, spider, and others. According to the report, snake represented the largest segment.
Anti-venom Type Insights:
Polyvalent Anti-venom
Monovalent Anti-venom
A detailed breakup and analysis of the anti-venom market based on the anti-venom type has also been provided in the report. This includes polyvalent and monovalent anti-venom. According to the report, polyvalent anti-venom accounted for the largest market share.
Mode of Action Insights:
Cytotoxic
Neurotoxic
Haemotoxic
Cardiotoxic
Myotoxic
Others
The report has provided a detailed breakup and analysis of the anti-venom market based on the mode of action. This includes cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others. According to the report, neurotoxic represented the largest segment.
End User Insights:
Hospitals
Clinics
Ambulatory Surgical Centers
A detailed breakup and analysis of the anti-venom market based on the end user has also been provided in the report. This includes hospitals, clinics, and ambulatory surgical centers. According to the report, hospitals accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anti-venom. Some of the factors driving the North America anti-venom market included the increasing incidence of snake bites, the introduction of numerous favorable government initiatives, and the thriving travel and tourism sector.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global anti-venom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc., and Rare Disease Therapeutics Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. What was the size of the global anti-venom market in 2023?
- 2. What is the expected growth rate of the global anti-venom market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global anti-venom market?
- 4. What are the key factors driving the global anti-venom market?
- 5. What is the breakup of the global anti-venom market based on the species?
- 6. What is the breakup of the global anti-venom market based on the anti-venom type?
- 7. What is the breakup of the global anti-venom market based on the mode of action?
- 8. What is the breakup of the global anti-venom market based on the end user?
- 9. What are the key regions in the global anti-venom market?
- 10. Who are the key players/companies in the global anti-venom market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-venom Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Species
- 6.1 Snake
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Scorpion
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Spider
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Anti-venom Type
- 7.1 Polyvalent Anti-venom
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Monovalent Anti-venom
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Mode of Action
- 8.1 Cytotoxic
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Neurotoxic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Haemotoxic
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Cardiotoxic
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Myotoxic
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Boehringer Ingelheim International GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Boston Scientific Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 CSL Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Incepta Pharmaceuticals Limited
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck & Co. Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck KGaA
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 MicroPharm Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Rare Disease Therapeutics Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
List of Figures
- Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
- Figure 2: Global: Anti-venom Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2023
- Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2023
- Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2023
- Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2023
- Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2023
- Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: North America: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: United States: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Canada: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: China: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Japan: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: India: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: South Korea: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Australia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Europe: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Germany: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: France: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Italy: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Spain: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Russia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Latin America: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Brazil: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Mexico: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2023
- Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 88: Global: Anti-venom Industry: SWOT Analysis
- Figure 89: Global: Anti-venom Industry: Value Chain Analysis
- Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anti-venom Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million US$), 2024-2032
- Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million US$), 2024-2032
- Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
- Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Anti-venom Market: Competitive Structure
- Table 8: Global: Anti-venom Market: Key Players
